Health Inside Biotech: FDA says ‘one and done’ — what it means for biotech globally By Proactive 23/02
Financial Services Three things to watch in the week ahead: Coles, Qantas, Nvidia earnings By Proactive 23/02
Finance US Supreme Court rules against Trump’s tariffs, raising questions for trade policy By Proactive 20/02
Energy Record Resources bets on Gabon offshore oil with low-cost, high-upside joint venture By Proactive 19/02
Retail & consumer Jobs growth keeps labour market ‘in rude health’, sharpening RBA’s inflation focus By Proactive 19/02
Pharma & Biotech Inside Biotech: Percheron maps out phase II push for next-generation VISTA inhibitor By Proactive 19/02
Hardware & electrical equipment Tech Bytes: Life360 expands Uber tie-up with in-app ride tracking and teen account integration By Proactive 18/02
Investments and investor services Britons say they need nearly £9,000 in cash before opening Stocks and Shares ISA, research finds By Proactive 16/02
Financial Services Tech Bytes: ASX tech bounces — but the ‘AI rerate’ isn’t done yet By Proactive 16/02
Financial Services Three things to watch in the week ahead: AU unemployment, BHP & JB Hi-Fi's earnings By Proactive 16/02
Medical technology & services Inside Biotech: Heavyweights feel the heat as results season bites By Proactive 13/02
Pharma & Biotech Inside Biotech: Trial tweaks, TGA clearance and US site openings headline busy day for biotechs By Proactive 11/02
